Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J OTC Business Returns To Double-Digit U.S. Growth In Q1

This article was originally published in The Tan Sheet

Executive Summary

The domestic OTC/nutritionals business grew more than 14% in the first quarter on the strength of McNeil products returning to market and a severe cold and flu season. Johnson & Johnson’s consumer performance exceeded some market analyst estimates.

Advertisement

Related Content

J&J Shines Spotlight On U.S. OTC Sales Growth
J&J Shines Spotlight On U.S. OTC Sales Growth
Perrigo Campaigns For Rational OTC Shopping Over Brand Loyalty
Perrigo Campaigns For Rational OTC Shopping Over Brand Loyalty
Korea Suspends Production Of 5 Janssen Products
Korea Suspends Production Of 5 Janssen Products
J&J Prioritizes OTC Return With McNeil Remediation End In Sight
J&J Will Boost OTC Marketing Once Reliable Production Returns
Chattem To Revive Rolaids Line Bought From J&J
With Zyrtec In Front, Consumer Segment Leads J&J’s Performance

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106353

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel